CD79A and T-cell non-Hodgkin lymphoma: Approximately 10-15% of DLBCLs remain unclassifiable, and immunophenotyping and morphological analysis are critical to distinguish between B-cell and T-cell lymphomas, using markers such as CD3, CD5, CD20, and CD79a.